當前位置：首頁 SCI期刊 SCIE期刊醫學中科院2區 JCRQ1 期刊介紹(非官網)

NeoplasiaSCIE

國際簡稱：NEOPLASIA 參考譯名：瘤形成

中科院分區
2區
CiteScore分區
Q2
JCR分區
Q1

基本信息：: ISSN：1476-5586; E-ISSN：1476-5586; 是否OA：開放; 是否預警：否; TOP期刊：是

出版信息：: 出版地區：UNITED STATES; 出版商：Neoplasia Press; 出版語言：English; 出版周期：Monthly; 出版年份：1999; 研究方向：ONCOLOGY

評價信息：: 影響因子：6.3; H-index：115; CiteScore指數：9.2; SJR指數：1.887; SNIP指數：1.225

發文數據：: Gold OA文章占比：98.62%; 研究類文章占比：94.87%; 年發文量：78; 自引率：0.0208...; 開源占比：0.9596; 出版撤稿占比：0; 出版國人文章占比：0.17; OA被引用占比：1

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Neoplasia期刊介紹

Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.

期刊簡介Neoplasia期刊介紹

《Neoplasia》自1999出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間： 12 Weeks
國際TOP期刊
醫學
ONCOLOGY
SCIE
中科院2區
非預警

Cite Score數據（2024年最新版）Neoplasia Cite Score數據

CiteScore：9.2
SJR：1.887
SNIP：1.225

學科類別	分區	排名	百分位
大類：Biochemistry, Genetics and Molecular Biology 小類：Cancer Research	Q2	60 / 230	74%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Neoplasia 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	2區	ONCOLOGY 腫瘤學	2區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Neoplasia JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：ONCOLOGY	SCIE	Q1	48 / 322	85.2%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：ONCOLOGY	SCIE	Q1	45 / 322	86.18%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
USA132
CHINA MAINLAND68
GERMANY (FED REP GER)28
Japan15
Canada13
Taiwan13
England12
Italy12
Switzerland12
Australia11

本刊中國學者近年發表論文

1、FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
Author: Tang, Qingyun; Liu, Cheng; Zhang, Shengwei; He, Lijiao; Liu, Yunyi; Wang, Jing; Zhao, Xiaoyan; Li, Xinzhe

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100863
2、Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model
Author: Wang, Jie; Sud, Shivani; Qu, Yanli; Li, Liantao; Zhang, Jiajie; Marron, David; Knape, Nicole Michelle; Kim, Isaiah James; Wagner, Kyle Thomas; Zhang, Tian; Zhao, Yuxia; Guo, Genyan; Wang, Andrew Z.

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100864
3、The children's brain tumor network (CBTN)-Accelerating research in pediatric central nervous system tumors through collaboration and open science
Author: Lilly, Jena, V; Rokita, Jo Lynne; Mason, Jennifer L.; Patton, Tatiana; Stefankiewiz, Stephanie; Higgins, David; Trooskin, Gerri; Larouci, Carina A.; Arya, Kamnaa; Appert, Elizabeth; Heath, Allison P.; Zhu, Yuankun; Brown, Miguel A.; Zhang, Bo; Farrow, Bailey K.; Robins, Shannon; Morgan, Allison M.; Nguyen, Thinh Q.; Frenkel, Elizabeth; Lehmann, Kaitlin; Drake, Emily; Sullivan, Catherine; Plisiewicz, Alexa; Coleman, Noel; Patterson, Luke; Koptyra, Mateusz; Helili, Zeinab; Van Kuren, Nicholas; Young, Nathan; Kim, Meen Chul; Friedman, Christopher; Lubneuski, Alex; Blackden, Christopher; Williams, Marti; Baubet, Valerie; Tauhid, Lamiya; Galanaugh, Jamie; Boucher, Katie; Ijaz, Heba; Cole, Kristina A.; Choudhari, Namrata; Santi, Mariarita; Moulder, Robert W.; Waller, Jonathan; Rife, Whitney; Diskin, Sharon J.; Mateos, Marion; Parsons, Donald W.; Pollack, Ian F.; Goldman, Stewart; Leary, Sarah; Caporalini, Chiara; Buccoliero, Anna Maria; Scagnet, Mirko; Haussler, David; Hanson, Derek; Firestein, Ron; Cain, Jason; Phillips, Joanna J.; Gupta, Nalin; Mueller, Sabine; Grant, Gerald; Monje-Deisseroth, Michelle; Partap, Sonia; Greenfield, Jeffrey P.; Hashizume, Rintaro; Smith, Amy; Zhu, Shida; Johnston, James M.; Fangusaro, Jason R.; Miller, Matthew; Wood, Matthew D.; Gardner, Sharon; Carter, Claire L.; Prolo, Laura M.; Pisapia, Jared; Pehlivan, Katherine; Franson, Andrea; Niazi, Toba; Rubin, Josh; Abdelbaki, Mohamed; Ziegler, David S.; Lindsay, Holly B.; Stucklin, Ana Guerreiro; Gerber, Nicolas; Vaske, Olena M.; Quinsey, Carolyn; Rood, Brian R.; Nazarian, Javad; Raabe, Eric; Jackson, Eric M.; Stapleton, Stacie; Lober, Robert M.; Kram, David E.; Koschmann, Carl; Storm, Phillip B.; Lulla, Rishi R.; Prados, Michael; Resnick, Adam C.; Waanders, Angela J.

Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100846
4、Fusobacterium nucleatum stimulates cell proliferation and promotes PD-L1 expression via IFIT1-related signal in colorectal cancer
Author: Gao, Yaqi; Zou, Tianhui; Xu, Pingping; Wang, Yingchao; Jiang, Yi; Chen, Ying-Xuan; Chen, Haoyan; Hong, Jie; Fang, Jing-Yuan

Journal: NEOPLASIA. 2023; Vol. 35, Issue , pp. -. DOI: 10.1016/j.neo.2022.100850
5、A trio of tumor suppressor miRNA downregulates CREB5 dependent transcription to modulate neoadjuvant hormonal therapy sensitivity
Author: Wang, Xueli; Han, Bo; Dou, Baokai; Gao, Lin; Sun, Feifei; Qi, Mei; Zhang, Jing; Hu, Jing

Journal: NEOPLASIA. 2023; Vol. 36, Issue , pp. -. DOI: 10.1016/j.neo.2022.100875
6、Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients-Knowledge from two independent international studies
Author: Zhou, Jian-Guo; Liang, Rui; Wang, Hai-Tao; Jing, Su-Han; Hu, Wei; Frey, Benjamin; Fietkau, Rainer; Hechth, Markus; Ma, Hu; Gaipl, Udo S.

Journal: NEOPLASIA. 2023; Vol. 37, Issue , pp. -. DOI: 10.1016/j.neo.2023.100877
7、Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors
Author: Bai, Yongkan; Liu, Xiang; Zheng, Limin; Wang, Song; Zhang, Junli; Xiong, Shi; Zhang, Pengfei; Jiao, Zichen; Zhao, Gefei; Zhou, Chu; Pang, Jiaohui; Xu, Yang; Ou, Qiuxiang; Mao, Yuan; Zhang, Louqian

Journal: NEOPLASIA. 2023; Vol. 38, Issue , pp. -. DOI: 10.1016/j.neo.2023.100888
8、Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells
Author: Shui, Yifang; Hu, Xin; Hirano, Hiroshi; Tsukamoto, Hirotake; Guo, Wen-Zhi; Hasumif, Kenichiro; Ijima, Fumihiro; Fujino, Masayuki; Li, Xiao-Kang

Journal: NEOPLASIA. 2023; Vol. 39, Issue , pp. -. DOI: 10.1016/j.neo.2023.100893